Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Aphios obtains funding from NIAID to develop cure for HIV/AIDS

Sep. 15, 2016

Janssen-Cilag submits MAA to EMA for darunavir-based single tablet regimen

Sep. 13, 2016

New York Blood Center patents anti-HIV antibody-drug conjugates

Sep. 8, 2016

European Commission grants marketing authorization to Gilead's Truvada

Aug. 23, 2016

Viiv Healthcare starts phase III trial for two-drug regimen of dolutegravir/lamivudine

Aug. 18, 2016

Genmab and Gilead Sciences enter DuoBody license agreement

Aug. 11, 2016

ANXA1 signaling as a novel therapeutic target for the resolution of immune dysfunction in HIV

Aug. 11, 2016

NIH awards a new contract to the IAVI to advance AIDS vaccine development

Aug. 10, 2016

GeoVax awarded contract from NIH to further develop HIV vaccine

Aug. 3, 2016

Janssen files for approval of darunavir/cobicistat combination tablets in Japan

July 29, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...